ORTORE, GABRIELLA MARIA PIA
 Distribuzione geografica
Continente #
NA - Nord America 4.017
EU - Europa 1.917
AS - Asia 1.383
AF - Africa 39
SA - Sud America 8
OC - Oceania 3
Totale 7.367
Nazione #
US - Stati Uniti d'America 3.919
CN - Cina 878
IT - Italia 801
SE - Svezia 281
DE - Germania 264
SG - Singapore 213
BG - Bulgaria 171
TR - Turchia 156
CA - Canada 98
GB - Regno Unito 81
UA - Ucraina 79
FR - Francia 67
VN - Vietnam 64
FI - Finlandia 63
CH - Svizzera 28
IN - India 28
HK - Hong Kong 22
AT - Austria 20
CI - Costa d'Avorio 17
BE - Belgio 14
RU - Federazione Russa 12
SN - Senegal 11
CZ - Repubblica Ceca 10
ES - Italia 8
PK - Pakistan 8
IR - Iran 7
NG - Nigeria 7
BR - Brasile 6
PL - Polonia 6
JP - Giappone 4
NL - Olanda 4
BJ - Benin 3
AU - Australia 2
DK - Danimarca 2
HU - Ungheria 2
BN - Brunei Darussalam 1
CL - Cile 1
CO - Colombia 1
EE - Estonia 1
IL - Israele 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 7.367
Città #
Woodbridge 584
Ann Arbor 523
Chengdu 507
Houston 417
Fairfield 350
Chandler 318
Ashburn 243
Milan 190
Sofia 171
Serra 135
Seattle 132
Wilmington 131
Izmir 126
Beijing 121
Pisa 112
Jacksonville 107
New York 104
Singapore 101
Cambridge 100
Ottawa 94
Boardman 86
Princeton 72
Nanjing 68
Lawrence 66
Medford 52
Dearborn 44
Des Moines 38
Florence 36
Boulder 34
Dong Ket 30
Istanbul 30
Marseille 30
Nanchang 28
Bern 26
San Diego 26
Hong Kong 21
Ogden 20
Rome 20
Jüchen 19
Los Angeles 19
Abidjan 17
Kunming 17
London 17
Redwood City 17
Trieste 17
Vienna 17
Nürnberg 16
Brussels 13
Pescara 13
Fuzhou 12
Tianjin 12
Dakar 11
Genoa 11
Hangzhou 11
Dallas 10
Falls Church 10
Hebei 10
Pessac 10
Shenyang 10
Bergamo 9
Brno 9
Guangzhou 9
Jiaxing 9
Carrara 8
Frankfurt am Main 8
Hyderabad 8
Washington 8
Bremen 7
Changsha 7
Lagos 7
Norwalk 7
Bures-sur-Yvette 6
Chicago 6
Hefei 6
Livorno 6
Lucca 6
Munich 6
Pune 5
Santa Clara 5
Shanghai 5
Lanzhou 4
Montopoli in Val d'Arno 4
Orange 4
Pistoia 4
San Francisco 4
Sun Prairie 4
Talence 4
Warsaw 4
Aradeo 3
Auburn Hills 3
Casorate Sempione 3
Chennai 3
Cotonou 3
Gif-sur-yvette 3
Helsinki 3
Indiana 3
Karachi 3
Lancaster 3
Lappeenranta 3
Middleton 3
Totale 5.797
Nome #
null 595
1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptors. 185
Salicylaldoxime derivatives as new leads for the development of carbonic anhydrase inhibitors 162
Synthesis of Anthranylaldoxime Derivatives as Estrogen Receptor Ligands and Computational Prediction of Binding Modes 151
Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands 147
Synthesis and dopaminergic properties of the two enantiomers of 3-(3,4-dimethylphenyl)-1-propylpiperidine, a potent and selective dopamine D4 receptor ligand 143
Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands 143
D3 dopamine receptor subtype: which binding modes for such different ligands?, 141
Computational studies of EGFR inhibitors: Docking, 3D-QSAR analysis and virtual screening evaluation 140
Cannabinoid CB2/CB1 Selectivity. Receptor Modeling and Automated Docking Analysis 128
A Virtual Screening Study for Lactate Dehydrogenase 5 Inhibitors by using a Pharmacophore-Based Approach 128
Identification of new FYN kinase inhibitors using a FLAP-based approach 126
D3 dopamine receptor subtype: which binding modes for such different ligands? 119
Development of a receptor-based 3D-QSAR study for the analysis of MMP2, MMP3, and MMP9 inhibitors 119
Multitemplate Alignment Method for the Development of a Reliable 3D-QSAR Model for the Analysis of MMP3 Inhibitors 119
Computational Studies on Translocator Protein (TSPO) and its Ligands 118
New N-n-propyl-substituted 3-Aryl and 3-Cyclohexyl piperidines as partial agonists at the D4 dopamine receptor 118
null 117
Pharmacophore based receptor modeling: the case of adenosine A3 receptor antagonists. An approach to the optimization of protein models 117
Targeting Different Transthyretin Binding Sites with Unusual Natural Compounds 117
Design of transthyretin amyloidosis inhibitors: A docking and virtual screening approach 116
Focus on Human Monoamine Transporter Selectivity. New Human DAT and NET Models, Experimental Validation, and SERT Affinity Exploration 113
Different Binding Modes of Structurally Diverse Ligands for Human D3DAR 112
Synthesis and prostaglandin synthase inhibitory activity of new aromatic O-alkyloxime ethers substituted with methylsulfonamido or methylsulfonyl groups on their aliphatic portion 111
Analysis of Human Carbonic Anhydrase II: Docking Reliability and Receptor-Based 3D-QSAR Study 110
Novel Transthyretin Amyloid Fibril Formation Inhibitors: Synthesis, Biological Evaluation, and X-Ray Structural Analysis 109
The cannabinoid CB2/CB1 selectivity. Homology modelling and automated docking analysis 106
Transthyretin amyloidosis: a computational approach toward the design of new inhibitors 106
Structure-based virtual screening: Identification of novel CB2 receptor ligands 104
Synthesis and COX2 inhibitory properties of N-Phenyl-and N-benzyl-substituted amides of 2-(4-methylsulfonylphenyl)cyclopent-1-ene-1-carboxylic acid and of their pyrazole, thiophene, and isoxazole analogs 103
null 103
Discovery of Novel Adenosine Receptor Antagonists through a Combined Structure- and Ligand-Based Approach Followed by Molecular Dynamics Investigation of Ligand Binding Mode 102
Aryl-substituted methyleneaminoxymethyl (MAOM) analogues of diarylcyclopentenyl cyclooxygenase-2 inhibitors: effects of some structural modifications on their biological properties 101
Adenosine receptor modelling. A1/A2a selectivity 101
A theoretical study to investigate D2DAR/D4DAR selectivity: Receptor modeling and molecular docking of dopaminergic ligands 100
Novel Estrogen Receptor Ligands Based on an Anthranylaldoxime Structure: Role of the Phenol-Type Pseudocycle in the Binding Process 99
Exploring the binding of quercetin-3-O-metabolites with transthyretin 99
Study on Affinity Profile toward Native and Bovine Adenosine Receptors of a Series of 1,8-Naphthyridine Derivatives 98
Aromatic aldoximes as Estrogen Receptor Beta–Selective Ligands 96
Confronto fra le affinità verso i recettori adenosinici umani e bovini di ligandi selettivi 1,8-naftiridinici. 95
SERINE PALMITOYLTRANSFERASE INHIBITION: A VIRTUAL SCREENING HYPOTHESIS 93
MMPs selectivity: Docking and 3D-QSAR evaluation 92
null 92
Predictions of binding of estrogen receptor agonists by a combination of molecular dynamics and continuum solvent models 80
Molecular docking of new highly potent A1 antagonists: theoretical study of a1 selectivity and species specificity in ligand binding 79
Alternatives to phenol-based estrogen receptor ligands 77
Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB2R) 75
Identification of Transthyretin Fibril Formation Inhibitors Using Structure-Based Virtual Screening 75
Identification of histone deacetylase inhibitors with (arylidene)aminoxy scaffold active in uveal melanoma cell lines 74
Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands 70
null 69
CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulators 69
Transthyretin: A Small Protein in the Big World of Amyloidoses 68
New inhibitors of transthyretin amyloid fibril formation 68
Nuovi derivati 3-fenil- e 3-cicloesil-piperidinici ad attività agonista sui recettori D4: un nuovo approccio per lo studio del deficit di attenzione con iperattività? 65
null 65
New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2 64
Diphenyl-methane based thyromimetic inhibitors for transthyretin amyloidosis 62
Salicil- ed antranil-aldossime ad azione estrogenica: ruolo dell’anello pseudo-fenolico 61
Homology Modelling and Receptor-Based 3D-QSAR study of Carbonic Anhydrase IX 60
Sintesi e proprietà inibitrici nei confronti delle cicloossigenasi di ammidi dell'acido 2-(4-metilsulfonilfenil)-1-ciclopentenico e di suoi analoghi eteroaromatici 60
From Paroxetine to new chromane oxime ether derivatives: a novel scaffold for SERT inhibitors. 60
Derivati 1,8 naftiridinici: selettività e docking nei recettori adenosinico 59
Synthesis and biological properties of 1,8-naphthyridin-4(1H)-on-3-carboxamide derivatives as selective CB2 cannabinoid receptor ligands 58
Docking of hydroxamic acids into HDAC1 and HDAC8: a rationalization of activity trends and selectivities 57
Selettività verso i recettori adenosinici: uno studio di modellazione molecolare 53
Studio teorico di ligandi selettivi per i recettori adenosinici 50
Computational Studies on Transthyretin 42
Docking of Hydroxamic Acids into HDAC1 and HDAC8: A Rationalization of Activity Trends and Selectivities 39
Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a New Class of Benzylpiperidine Derivatives 37
Machine Learning-Based Virtual Screening for the Identification of Cdk5 Inhibitors 36
A STRUCTURE-BASED VIRTUAL SCREENING TO IDENTIFY NEW SCAFFOLDS FOR TRANSTHYRETIN FIBRIL FORMATION INHIBITORS 36
From Anti-infective Agents to Cancer Therapy: a Drug Repositioning Study Revealed a New Use for Nitrofuran Derivatives 35
INTERACTION OF AMINOADAMANTANE DERIVATIVES WITH THE INFLUENZA A VIRUS M2 CHANNEL – COMPARATIVE DOCKING CALCULATIONS USING A PORE BLOCKING MODEL AND AN ALLOSTERIC MODEL 34
Virtual screening and crystallographic studies reveal an unexpected γ-lactone derivative active against MptpB as a potential antitubercular agent 28
A2B Receptor Ligands: Past, Present and Future Trends 28
Identification of Human Dihydroorotate Dehydrogenase Inhibitor by a Pharmacophore-Based Virtual Screening Study 25
Molecular Modeling of Adenosine ReceptorsG Protein Coupled Receptors - Modeling, Activation, Interactions and Virtual Screening 22
Synthesis and Evaluation of Monoaryl Derivatives as Transthyretin Fibril Formation Inhibitors 21
Thyroxine metabolite-derived 3-iodothyronamine (T1AM) and synthetic analogs as efficient suppressors of transthyretin amyloidosis 19
Synthesis, molecular docking and binding studies of selective serotonin transporter inhibitors 19
Interaction of aminoadamantane derivatives with the influenza A virus M2 channel-Docking using a pore blocking model 16
Totale 7.509
Categoria #
all - tutte 19.913
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.913


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020697 0 0 0 0 97 117 133 87 97 73 77 16
2020/2021474 42 20 27 15 48 40 42 56 35 26 42 81
2021/2022770 22 76 20 24 141 105 28 37 26 28 57 206
2022/2023988 100 116 68 83 91 155 11 66 164 5 47 82
2023/2024973 131 104 98 72 133 145 93 14 12 23 41 107
2024/2025318 22 91 50 139 16 0 0 0 0 0 0 0
Totale 7.509